Summary:
Pfizer’s Braftovi combination therapy shows improved progression-free survival in Phase III BREAKWATER study for colorectal cancer, setting stage for potential full approval in BRAF V600E mutated cases.
Summary:
Health nominee Kennedy faces Senate scrutiny over vaccine positions, pledges pro-safety stance. Democrats challenge past statements while Republican questions focus on abortion, rural healthcare.
Summary:
Cargo Therapeutics halts lead lymphoma cell therapy program after Phase 2 results show high immune reactions and declining remission rates. Company cuts workforce by 50% and shifts focus to early-stage research.
Summary:
Novartis reports strong Q4 growth with $13.1B in sales, plans to continue aggressive dealmaking after 30 partnerships in 2024. CEO Narasimhan focuses on bolt-on acquisitions for 2030+ growth.
Summary:
Scientists explore microbes’ diverse roles in space missions, from mining rare-earth metals to making medicines and building materials. ISS experiments show promise, but space microbiology poses unique challenges in microgravity.
